Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
Aptarion Biotech AG
Aptarion Biotech AG
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
Albert Einstein College of Medicine
Hospices Civils de Lyon
Assistance Publique - Hôpitaux de Paris
Brigham and Women's Hospital
RenJi Hospital
King's College London
University of Sydney
National Cancer Institute (NCI)
University Hospital Schleswig-Holstein
University Magna Graecia
The Cooper Health System
Mitera Hospital
North Sichuan Medical College
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Duke-NUS Graduate Medical School
University of Zurich
Hubei Cancer Hospital
Central TB Research Institute
BioAegis Therapeutics Inc.
University Hospital Augsburg
Johannes Gutenberg University Mainz
Mayo Clinic
Duke University
M.D. Anderson Cancer Center
Azienda Sanitaria-Universitaria Integrata di Udine
Carebot s.r.o.
AstraZeneca
National Institute for Tuberculosis and Lung Diseases, Poland
Xijing Hospital
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Hospital General Universitario de Valencia
Royal Marsden NHS Foundation Trust
Nantes University Hospital
Guangzhou Institute of Respiratory Disease
National Heart, Lung, and Blood Institute (NHLBI)
Milton S. Hershey Medical Center
CHU de Reims
Hospital General Universitario de Valencia
M.D. Anderson Cancer Center
National Cancer Center, Korea
Fudan University
Radboud University Medical Center
St. James's Hospital, Ireland
Universitätsmedizin Mannheim
Instituto Nacional de Cancerologia de Mexico
Memorial Sloan Kettering Cancer Center